A Study of DC-CIK to Treat Hepatocellular Carcinoma

Clinical trial NCT01821482 · UNKNOWN

Trial details

NCT number: NCT01821482
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2013-05-01
Primary completion: 2018-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.